Navigation Links
China-Biotics to Report Fiscal Year 2011 First Quarter Financial Results on August 9
Date:7/23/2010

SHANGHAI, July 23 /PRNewswire-Asia-FirstCall/ -- China-Biotics, Inc. ("China-Biotics", the "Company") (Nasdaq: CHBT), the leading developer, manufacturer and distributor of probiotics products in China, today announced it will host a conference call at 08:00 a.m. Eastern Daylight Time on Monday, August 9, 2010 to discuss the fiscal year 2011 first quarter financial results for the period ended June 30, 2010.

The telephone numbers for the conference call are (866) 783-2138 (U.S.) or (857) 350-1597 (International), passcode: 76874068. A live web cast of the call will also be available on the investor relations section of the Company's website http://www.chn-biotics.com . To listen to the web cast, please visit the site at least 10 minutes early to register, download and install any necessary audio software.

The replay of the web cast will be archived on the website, and investors will be able to access the recording of the conference call until midnight EDT on August 16, 2010 by calling (888) 286-8010 (U.S.) or (617) 801-6888 (International) and entering passcode: 75529413.

About China-Biotics

China-Biotics, Inc. ("China-Biotics," "the Company"), a leading manufacturer of biotechnology products and supplements, engages in the research, development, marketing and distribution of probiotics dietary supplements in China. Through its wholly owned subsidiary, Shanghai Shining Biotechnology Co., Ltd., the Company develops and produces its proprietary product portfolio including live microbial nutritional supplements under the "Shining" brand. Currently, the products are sold OTC through large distributors to pharmacies and supermarkets in Shanghai, Jiangsu, and Zhejiang province. In February 2010, China-Biotics began its commercial production in China's largest probiotics production facility to meet growing demand in China. For more information, please visit http://www.chn-biotics.com .

    For more information, please contact:

     Travis Cai
     Chief Financial Officer
     China-Biotics, Inc.
     Email: traviscai@chn-biotics.com

     Kevin Theiss
     Grayling
     Phone: +1-646-284-9409
     Email: kevin.theiss@grayling.com


'/>"/>
SOURCE China-Biotics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. China-Biotics Provides Further Updates on Qingpu New Facility
2. China-Biotics, Inc. Reports Record Quarterly and Annual Revenue Growth for Fiscal Year 2010
3. China-Biotics to Report Fourth Quarter and Fiscal Year 2010 Financial Results on June 11
4. China-Biotics to Present at Bank of America Merrill Lynch Healthcare Event on June 22
5. China-Biotics Provides Updates on Qingpu New Facility and Chinese Probiotics Market
6. China-Biotics, Inc. Appointed Grayling as Strategic Investor Relations Advisor
7. China-Biotics, Inc. Inaugurated the Commercial Production of its New Production Facility
8. China-Biotics, Inc. Reports Third Quarter Fiscal 2010 Financial Results
9. China-Biotics, Inc. Announces Conference Call to Discuss Second Quarter Fiscal 2010 Financial Results
10. China-Biotics, Inc. Appoints New Vice President
11. China-Biotics, Inc. to Attend the SIG 3rd Annual Beijing Management Summit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016   EpiBiome , ... secured $1 million in debt financing from Silicon Valley ... up automation and to advance its drug development efforts, ... new facility. "SVB has been an incredible ... the services a traditional bank would provide," said Dr. ...
(Date:6/23/2016)... ... June 23, 2016 , ... STACS DNA Inc., the sample tracking software company, ... Crime Laboratory, has joined STACS DNA as a Field Application Specialist. , “I ... President and COO of STACS DNA. “In further expanding our capacity as a scientific ...
(Date:6/23/2016)... 2016 Apellis Pharmaceuticals, Inc. today announced ... of its complement C3 inhibitor, APL-2. The trials ... dose studies designed to assess the safety, tolerability, ... in healthy adult volunteers. Forty subjects ... single dose (ranging from 45 to 1,440mg) or ...
(Date:6/23/2016)... 23, 2016 Andrew ... http://doi.org/10.17925/OHR.2016.12.01.22 Published recently in ... journal from touchONCOLOGY, Andrew D Zelenetz , ... cancer care is placing an increasing burden on ... biologic therapies. With the patents on many biologics ...
Breaking Biology Technology:
(Date:6/3/2016)... , June 3, 2016 ... von Nepal hat ... Lieferung hochsicherer geprägter Kennzeichen, einschließlich Personalisierung, Registrierung ... in der Produktion und Implementierung von Identitätsmanagementlösungen. ... Ausschreibung im Januar teilgenommen, aber Decatur wurde ...
(Date:6/1/2016)... NEW YORK , June 1, 2016 ... Biometric Technology in Election Administration and Criminal Identification to ... According to a recently released TechSci Research report, " ... Sector, By Region, Competition Forecast and Opportunities, 2011 - ... $ 24.8 billion by 2021, on account of growing ...
(Date:5/12/2016)... May 12, 2016 WearablesResearch.com , a ... the overview results from the Q1 wave of its ... wave was consumers, receptivity to a program where they ... a health insurance company. "We were surprised ... says Michael LaColla , CEO of Troubadour Research, ...
Breaking Biology News(10 mins):